Action International Coal G - ICO

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

14,59

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

14,59

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

EDISON EQUITY RESEARCH - ICO THERAPEUTICS

EDISON EQUITY RESEARCH: ICO THERAPEUTICS - MOVING FORWARD WITH ORALAMPB iCo is deploying C$0.7m in grant funding to move ahead with preclinical...

Immune Appoints Cameron Durrant, MD, MBA to Board of Directors

NEW YORK and HERZLIYA-PITUACH, Israel, July 14, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) ("Immune" or "the...

Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President

NEW YORK and HERZLIYA-PITUACH, Israel, June 6, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) ("Immune" or "the...

Immune Pharmaceuticals Announces First Quarter 2014 Financial Results

NEW YORK and HERZLIYA-PITUACH, Israel, May 21, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) and (Nasdaq:IMNP) ("Immune" or...

Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET

NEW YORK and HERZLIYA-PITUACH, Israel, May 5, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX: IMNP) (Nasdaq:IMNP) ("Immune" or the...

Immune Pharmaceuticals Announces Company Highlights and Reports Full Fiscal Year 2013 Financial Results

NEW YORK and HERZLIYA-PITUACH, Israel, April 10, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) and (Nasdaq:IMNP) ("Immune" or...

Immune CEO Announces New Operational Leadership Team

NEW YORK and HERZLIYA, Israel, April 2, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) announced today the...

Immune Pharmaceuticals Announces $11.7 Million Private Placement Financing

NEW YORK and HERZLIYA, Israel, March 10, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) announced today that it...

International Coal Group Announces Effective Date of Make-Whole Fundamental Change Relating to its 4.00% Convertible Senior Note

International Coal Group Announces Effective Date of Make-Whole Fundamental Change Relating to its 4.00% Convertible Senior Notes Due 2017 PR...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

ICO - Frequently Asked Questions (FAQ)

What is the current International Coal G share price?

The current share price of International Coal G is US$ 14,59

What is the 1 year trading range for International Coal G share price?

International Coal G has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
HLFHerbalife Ltd	US$ 8,02 (42,70%)	23,99M
UUnity Software Inc	US$ 28,00 (30,41%)	64,16M
TUYATuya Inc	US$ 3,88 (26,80%)	14,36M
MDPediatrix Medical Group Inc	US$ 17,24 (22,18%)	2,06M
CYDChina Yuchai International Ltd	US$ 18,73 (19,76%)	1,54M
PNSTPinstripes Holdings Inc	US$ 0,33 (-28,26%)	564,39k
JMIAJumia Technologies AG	US$ 2,8187 (-27,35%)	27,59M
TFIITFI International Inc	US$ 101,48 (-20,48%)	1,63M
MATVMativ Holdings Inc	US$ 7,46 (-17,93%)	1,24M
QUADQuad Graphics Inc	US$ 6,55 (-15,81%)	679,51k
BABAAlibaba Group Holding Limited	US$ 135,95 (8,08%)	118,89M
QBTSD Wave Quantum Inc	US$ 7,39 (13,00%)	110,76M
UUnity Software Inc	US$ 28,00 (30,41%)	64,16M
VALEVale SA	US$ 10,16 (4,31%)	61,78M
BBAIBigBear ai Holdings Inc	US$ 7,5084 (-4,59%)	55,55M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

International Coal Grp. (ICO)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

ICO Dernières nouvelles

EDISON EQUITY RESEARCH - ICO THERAPEUTICS

Immune Appoints Cameron Durrant, MD, MBA to Board of Directors

Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President

Immune Pharmaceuticals Announces First Quarter 2014 Financial Results

Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET

Immune Pharmaceuticals Announces Company Highlights and Reports Full Fiscal Year 2013 Financial Results

Immune CEO Announces New Operational Leadership Team

Immune Pharmaceuticals Announces $11.7 Million Private Placement Financing

International Coal Group Announces Effective Date of Make-Whole Fundamental Change Relating to its 4.00% Convertible Senior Note

ICO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

International Coal Grp. (ICO) Cours

International Coal Grp. (ICO)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

ICO Dernières nouvelles

EDISON EQUITY RESEARCH - ICO THERAPEUTICS

Immune Appoints Cameron Durrant, MD, MBA to Board of Directors

Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President

Immune Pharmaceuticals Announces First Quarter 2014 Financial Results

Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET

Immune Pharmaceuticals Announces Company Highlights and Reports Full Fiscal Year 2013 Financial Results

Immune CEO Announces New Operational Leadership Team

Immune Pharmaceuticals Announces $11.7 Million Private Placement Financing

International Coal Group Announces Effective Date of Make-Whole Fundamental Change Relating to its 4.00% Convertible Senior Note

ICO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE